Is RNAM or DIVO a better dividend investment in 2026?

RNAM currently yields 2.74% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between RNAM and DIVO?

RNAM has a forward dividend yield of 2.74% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 3.75 percentage points.

Home › Compare › RNAM vs DIVO

RNAM vs DIVO: Dividend Comparison 2026

RNAM yields 2.74% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DIVO wins by $6.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RNAM

● Live price

2.74%

Share price

$72.86

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$23.8K

Annual income

$327.66

Full RNAM calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — RNAM vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RNAM	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RNAM + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RNAM pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RNAM

Annual income on $10K today (after 15% tax)

$233.32/yr

After 10yr DRIP, annual income (after tax)

$278.51/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, DIVO beats the other by $555.92/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RNAM + DIVO for your $10,000?

RNAM: 50%DIVO: 50%

100% DIVO50/50100% RNAM

Portfolio after 10yr

$27.3K

Annual income

$654.67/yr

Blended yield

2.40%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on RNAM right now

RNAM

Analyst Ratings

Buy

Hold

Consensus: Hold

Altman Z

23.7

Piotroski

2/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RNAM buys

DIVO buys

No recent congressional trades found for RNAM or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRNAMDIVO

Forward yield	2.74%	6.49% ✓
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$23.8K	$30.7K ✓
Annual income after 10y	$327.66	$981.68 ✓
Total dividends collected	$3.0K	$8.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RNAM vs DIVO ($10,000, DRIP)

Year	RNAM Portfolio	RNAM Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$10,974	$274.50	$11,349	$649.42	$375.00 → DIVO
2	$12,024	$281.54	$12,833	$688.83	$809.00 → DIVO
3	$13,154	$288.29	$14,459	$727.90	$1.3K → DIVO
4	$14,370	$294.75	$16,238	$766.49	$1.9K → DIVO
5	$15,677	$300.92	$18,179	$804.47	$2.5K → DIVO
6	$17,081	$306.81	$20,293	$841.71	$3.2K → DIVO
7	$18,589	$312.42	$22,591	$878.14	$4.0K → DIVO
8	$20,208	$317.77	$25,087	$913.65	$4.9K → DIVO
9	$21,945	$322.84	$27,791	$948.18	$5.8K → DIVO
10	$23,809	$327.66	$30,718	$981.68	$6.9K → DIVO

RNAM vs DIVO: Complete Analysis 2026

RNAM — Stock

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Full RNAM Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this RNAM vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RNAM vs SCHD RNAM vs JEPI RNAM vs O RNAM vs KO RNAM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.